Originator Organization Stelexis Therapeutics LLCStartup |
Active Organization- |
Inactive Organization Stelexis Therapeutics LLCStartup |
Drug Highest PhasePendingEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 1 | US | Stelexis Therapeutics LLCStartup | 02 Dec 2021 |